XERIS PHARMACEUTICALS INC
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|
| Revenue | $20.2M | $1.6M | $0 | $16,000 |
| Operating income | −$83.5M | −$122.4M | −$59.3M | −$26.6M |
| Net income | −$91.1M | −$125.6M | −$60.1M | −$26.6M |
| Total assets | $159.2M | $109.0M | $120.0M | $45.0M |
| Total liabilities | $125.4M | $94.6M | $44.6M | $5.0M |
| Equity | $33.8M | $14.4M | $75.4M | −$57.8M |
| EPS (diluted) | — | — | — | — |
| Shares out. | 37.6M | 26.8M | — | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2020- Operating margin
- −414.5%
- Net margin
- −452.2%
- Return on equity
- −270.0%
- Return on assets
- −57.3%
- Return on capital (ROCE)
- −63.8%
- Liabilities / assets
- 78.8%
- Debt / equity
- 3.71×
- Book value / share
- $0.90
- Revenue growth (YoY)
- 1138.8%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2020- Altman Z″ (distress)
- -5.04distress
- Accruals / assets
- −6.6%clean
- Beneish M-Score
- 5.79elevated
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 5 warning● 2 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Beneish M-Score elevated — earnings-manipulation screen flag
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
FDA-approved drugs
openFDA · most recent- GVOKE KITSep 10, 2019
- KEVEYISJul 22, 1958
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Other material eventOct 5, 2021
- Entered a material agreement · New financial obligation · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventOct 5, 2021
- Shareholder vote · Other material eventSep 14, 2021
- Results of operationsAug 5, 2021
- Other material eventJul 30, 2021
- Director / officer changeJul 29, 2021
- Other material eventJul 19, 2021
- Shareholder voteJun 8, 2021
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 14, 2022
- 15-12BOct 15, 2021
- EFFECTOct 6, 2021
- 4FORM 4 SUBMISSIONOct 5, 2021
- 4FORM 4 SUBMISSIONOct 5, 2021
- 4FORM 4 SUBMISSIONOct 5, 2021
- 4FORM 4 SUBMISSIONOct 5, 2021
- 4FORM 4 SUBMISSIONOct 5, 2021
- 4FORM 4 SUBMISSIONOct 5, 2021
- 4FORM 4 SUBMISSIONOct 5, 2021
- 4FORM 4 SUBMISSIONOct 5, 2021
- 4FORM 4 SUBMISSIONOct 5, 2021
- 4FORM 4 SUBMISSIONOct 5, 2021
- 4FORM 4 SUBMISSIONOct 5, 2021
- 25-NSEOct 5, 2021
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.